BiotechTube
Home/Orega Biotech/Jeremy Bastid
JB

Jeremy Bastid

CEO

Orega Biotech

Therapeutic Areas

Oncology

Orega Biotech Pipeline

DrugIndicationPhase
IPH5201 (anti-CD39 mAb)Non-Small Cell Lung Cancer (NSCLC)Phase 2
Undisclosed Antibody ProgramUndisclosedPre-clinical

Leadership Team at Orega Biotech

GA
Gilles Alberici
Chairman
NB
Nathalie Bonnefoy
Founder & CSO
AB
Armand Bensussan
Founder
JE
Jean-François Eliaou
Founder
View full Orega Biotech profile